推荐同事 机构合作 中文 繁體中文 English 한국어 日本語 Português Español

美国ACCDON公司旗下品牌

021-33361733,021-33632861

chinasupport@letpub.com

登录 注册 新注册优惠

CANCER RESEARCH

2022年12月最新中科院JCR期刊分区表数据(升级版)已经更新,欢迎查询! 如果您对期刊系统有任何需求或者问题,欢迎点击此处反馈给我们。

按期刊名首写字母查看 CANCER RES最新评论:你好,想问下你何时和具体如何申诉的呢?是补做了审稿人意见的实验,然后拿实验结果去申诉?申诉的时候和接到拒稿消息隔了多久时... (2021-06-19)


期刊名:   ISSN:   研究方向:   影响因子: -   SCI收录:
大类学科:   小类学科:   中科院分区:   是否OA期刊:   结果排序:

按研究方向查看:


CANCER RESEARCH期刊基本信息Hello,您是该期刊的第261177位访客

基本信息 登录收藏
期刊名字CANCER RESEARCHCANCER RESEARCH

CANCER RES

LetPub评分
9.3
54人评分
我要评分

声誉
10.0

影响力
8.8

速度
9.2

期刊ISSN0008-5472
微信扫码收藏此期刊
E-ISSN1538-7445
2021-2022最新影响因子
(数据来源于搜索引擎)
13.312 点击查看影响因子趋势图
2021-2022自引率1.00%点击查看自引率趋势图
h-index 411
CiteScore
CiteScoreSJRSNIPCiteScore排名
16.303.0751.962
学科分区排名百分位
大类:Medicine
小类:Oncology
Q122 / 360
大类:Medicine
小类:Cancer Research
Q119 / 210

期刊简介Cancer Research is the most frequently cited cancer journal in the world. The journal publishes original studies, reviews, and opinion pieces offering significance and broad impact to a diverse audience spanning basic, preclinical, clinical, prevention and epidemiological research. Cancer Research seeks manuscripts that offer pathobiological and translational impact to inform the personal, clinical, and societal problems posed by cancer. The main scope of the Journal is captured in its primary subsections, which focus on molecular and cellular pathobiology, tumor and stem cell biology, therapeutics and targets, microenvironment and immunology, prevention and epidemiology, and integrated systems and technology.
期刊官方网站http://cancerres.aacrjournals.org/
期刊投稿网址http://can.msubmit.net/cgi-bin/main.plex
期刊语言要求经LetPub语言功底雄厚的美籍native English speaker精心编辑的稿件,不仅能满足CANCER RESEARCH的语言要求,还能让CANCER RESEARCH编辑和审稿人得到更好的审稿体验,让稿件最大限度地被CANCER RESEARCH编辑和审稿人充分理解和公正评估。LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)帮助作者准备稿件,已助力全球15万+作者顺利发表论文。部分发表范例可查看:服务好评 论文致谢
提交文稿
是否OA开放访问No
通讯方式AMER ASSOC CANCER RESEARCH, 615 CHESTNUT ST, 17TH FLOOR, PHILADELPHIA, USA, PA, 19106-4404
出版商American Association for Cancer Research Inc.
涉及的研究方向医学-肿瘤学
出版国家或地区UNITED STATES
出版语言English
出版周期Semimonthly
出版年份1941
年文章数 492点击查看年文章数趋势图
Gold OA文章占比2.51%
研究类文章占比:
文章 ÷(文章 + 综述)
92.48%
WOS期刊SCI分区
2021-2022年最新版
WOS分区等级:1区

按学科分区
ONCOLOGY Q3Q1Q2
中科院《国际期刊预警
名单(试行)》名单
2023年01月发布的2023版:不在预警名单中

2021年12月发布的2021版:不在预警名单中

2021年01月发布的2020版:不在预警名单中
中科院SCI期刊分区
2022年12月最新升级版
点击查看中科院SCI期刊分区趋势图
大类学科小类学科Top期刊综述期刊
医学 3区1区2区
ONCOLOGY
肿瘤学
2区2区1区
中科院SCI期刊分区
2021年12月基础版
大类学科小类学科Top期刊综述期刊
医学 2区1区3区
ONCOLOGY
肿瘤学
4区2区2区
中科院SCI期刊分区
2021年12月升级版
大类学科小类学科Top期刊综述期刊
医学 4区1区1区
ONCOLOGY
肿瘤学
3区3区1区
中科院SCI期刊分区
2020年12月旧的升级版
大类学科小类学科Top期刊综述期刊
医学 1区1区2区
ONCOLOGY
肿瘤学
2区2区1区
SCI期刊收录coverage Science Citation Index Expanded (SCIE) (2020年1月,原SCI撤销合并入SCIE,统称SCIE)
Scopus (CiteScore)
PubMed Central (PMC)链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=0008-5472%5BISSN%5D
平均审稿速度网友分享经验:
平均2.5月
平均录用比例网友分享经验:
约30%
LetPub助力发表经LetPub编辑的稿件平均录用比例是未经润色的稿件的1.5倍,平均审稿时间缩短40%。众多作者在使用LetPub的专业SCI论文编辑服务(包括SCI论文英语润色同行资深专家修改润色SCI论文专业翻译SCI论文格式排版专业学术制图等)后论文在CANCER RESEARCH顺利发表。
快看看作者怎么说吧:服务好评 论文致谢
期刊常用信息链接
同领域相关期刊 CANCER RESEARCH期刊近年CiteScore指标趋势图
该杂志的自引率趋势图 CANCER RESEARCH中科院SCI期刊分区趋势图
该杂志的年文章数趋势图 同领域作者分享投稿经验
CANCER RESEARCH上中国学者近期发表的论文  
  • 同领域相关期刊
  • 期刊CiteScore趋势图
  • 期刊自引率趋势图
  • 中科院SCI期刊分区趋势图
  • 年文章数趋势图
  • 该期刊中国学者近期发表论文
  • 中科院SCI期刊分区相关期刊
  • 同类著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144716.20
    NATURE REVIEWS CANCER39677.10
    Nature Reviews Clinical Oncology12763.50
    LANCET ONCOLOGY27456.90
    ANNALS OF ONCOLOGY21047.30
    JOURNAL OF CLINICAL ONCOLOGY49440.90
    CANCER CELL29541.90
    SEMINARS IN CANCER BIOLOGY13421.10
    CLINICAL CANCER RESEARCH29219.80
    CANCER TREATMENT REVIEWS11620.90
    中科院SCI期刊分区同大类学科的热搜期刊 浏览次数
    MEDICINE524727
    Frontiers in Pharmacology369508
    BIOMEDICINE & PHARMACOTHERAPY357793
    JOURNAL OF ETHNOPHARMACOLOGY329333
    Frontiers in Immunology326072
    Frontiers in Oncology314058
    Theranostics276395
    Molecular Medicine Reports269357
    International Journal of Nanomedicine267044
    CANCER LETTERS266479
  •  

    CANCER RESEARCH CANCER RESEARCH
    我来预测明年:
    稳步上升 表现平稳 逐渐下降  刷新
  •  

     
  •  

     
  •  

     
  • 中国学者近期发表的论文
    1.AKT as a Therapeutic Target for Cancer.

    Author: Song M#1,2, Bode AM#3, Dong Z4,2,3,5, Lee MH4,2,5.
    Journal: Cancer Res. 2019 Mar 15;79(6):1019-1031. doi: 10.1158/0008-5472.CAN-18-2738. Epub 2019 Feb 26.
        PubMed      DOI
    2.Retinoic Acid-Related Orphan Receptor C Regulates Proliferation, Glycolysis, and Chemoresistance via the PD-L1/ITGB6/STAT3 Signaling Axis in Bladder Cancer.

    Author: Cao D#1,2,3, Qi Z#4, Pang Y#5, Li H#2,3,6, Xie H7, Wu J1,3, Huang Y1,3, Zhu Y1,3, Shen Y1,3, Zhu Y1,3, Dai B1,3, Hu X2, Ye D8,2,3, Wang Z9,1.
    Journal: Cancer Res. 2019 May 15;79(10):2604-2618. doi: 10.1158/0008-5472.CAN-18-3842. Epub 2019 Feb 26.
        PubMed      DOI
    3.Stabilized Peptide HDAC Inhibitors Derived from HDAC1 Substrate H3K56 for the Treatment of Cancer Stem-Like Cells In Vivo.

    Author: Wang D1, Li W1, Zhao R1, Chen L1, Liu N1, Tian Y2, Zhao H3, Xie M1, Lu F1, Fang Q1, Liang W4, Yin F5, Li Z5.
    Journal: Cancer Res. 2019 Apr 15;79(8):1769-1783. doi: 10.1158/0008-5472.CAN-18-1421. Epub 2019 Mar 6.
        PubMed      DOI
    4.Genome-Wide RNAi Screen Identifies PMPCB as a Therapeutic Vulnerability in EpCAM+ Hepatocellular Carcinoma.

    Author: Takai A#1, Dang H#1,2, Oishi N#1, Khatib S1, Martin SP1, Dominguez DA1, Luo J3, Bagni R4, Wu X4, Powell K4, Ye QH5, Jia HL5, Qin LX5, Chen J6, Mitchell GA6, Luo X6, Thorgeirsson SS1, Wang XW7.
    Journal: Cancer Res. 2019 May 1;79(9):2379-2391. doi: 10.1158/0008-5472.CAN-18-3015. Epub 2019 Mar 12.
        PubMed      DOI
    5.EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.

    Author: Shen A#1,2, Chen Y#1,2,3, Liu L1,2,3, Huang Y1,2, Chen H1,2, Qi F1,2, Lin J1,2, Shen Z1,2, Wu X1,2, Wu M1,2, Li Q1,2, Qiu L1,2, Yu N1,2, Sferra TJ3, Peng J4,2.
    Journal: Cancer Res. 2019 May 1;79(9):2257-2270. doi: 10.1158/0008-5472.CAN-18-3238. Epub 2019 Mar 12.
        PubMed      DOI
    6.Combined Menin and EGFR Inhibitors Synergize to Suppress Colorectal Cancer via EGFR-Independent and Calcium-Mediated Repression of SKP2 Transcription.

    Author: Katona BW1,2, Glynn RA2, Paulosky KE2, Feng Z2, Davis CI3, Ma J2, Berry CT4,5, Szigety KM2, Matkar S2, Liu Y2, Wang H2, Wu Y2,6, He X2, Freedman BD4, Brady DC2, Hua X7.
    Journal: Cancer Res. 2019 May 1;79(9):2195-2207. doi: 10.1158/0008-5472.CAN-18-2133. Epub 2019 Mar 15.
        PubMed      DOI
    7.Regulation of miRNA Biogenesis and Histone Modification by K63-Polyubiquitinated DDX17 Controls Cancer Stem-like Features.

    Author: Kao SH1,2, Cheng WC1,2,3, Wang YT4, Wu HT5, Yeh HY1, Chen YJ4, Tsai MH6, Wu KJ7,2,3,8,9,10,11.
    Journal: Cancer Res. 2019 May 15;79(10):2549-2563. doi: 10.1158/0008-5472.CAN-18-2376. Epub 2019 Mar 15.
        PubMed      DOI
    8.CD317 Activates EGFR by Regulating Its Association with Lipid Rafts.

    Author: Zhang G1, Li X1, Chen Q1, Li J1, Ruan Q1, Chen YH2, Yang X3, Wan X4.
    Journal: Cancer Res. 2019 May 1;79(9):2220-2231. doi: 10.1158/0008-5472.CAN-18-2603. Epub 2019 Mar 19.
        PubMed      DOI
    9.Inhibition of miR-328-3p Impairs Cancer Stem Cell Function and Prevents Metastasis in Ovarian Cancer.

    Author: Srivastava AK#1, Banerjee A#1,2, Cui T#1, Han C1, Cai S1, Liu L1,3, Wu D1, Cui R4, Li Z5, Zhang X6, Xie G1, Selvendiran K7, Patnaik S2, Karpf AR8, Liu J9, Cohn DE7, Wang QE10,11.
    Journal: Cancer Res. 2019 May 1;79(9):2314-2326. doi: 10.1158/0008-5472.CAN-18-3668. Epub 2019 Mar 20.
        PubMed      DOI
    10.4E-BP1 Is a Tumor Suppressor Protein Reactivated by mTOR Inhibition in Head and Neck Cancer.

    Author: Wang Z1,2, Feng X1, Molinolo AA1, Martin D3, Vitale-Cross L3, Nohata N1, Ando M1, Wahba A4, Amornphimoltham P1,5, Wu X1, Gilardi M1, Allevato M1,6, Wu V1,6, Steffen DJ1,6, Tofilon P4, Sonenberg N7, Califano J1, Chen Q8, Lippman SM9, Gutkind JS9,6.
    Journal: Cancer Res. 2019 Apr 1;79(7):1438-1450. doi: 10.1158/0008-5472.CAN-18-1220. Epub 2019 Mar 20.
        PubMed      DOI
  • 同大类学科的其他著名期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144716.20
    LANCET700115.30
    NEW ENGLAND JOURNAL OF MEDICINE933110.50
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62238.80
    NATURE REVIEWS DRUG DISCOVERY28965.90
    NATURE REVIEWS IMMUNOLOGY35170.80
    Lancet Respiratory Medicine7961.60
    BMJ-British Medical Journal010.20
    BMJ-British Medical Journal010.20
    NATURE MEDICINE49791.90
    同分区等级的其他期刊名称 h-index CiteScore
    CA-A CANCER JOURNAL FOR CLINICIANS144716.20
    LANCET700115.30
    NEW ENGLAND JOURNAL OF MEDICINE933110.50
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION62238.80
    NATURE REVIEWS MOLECULAR CELL BIOLOGY386140.90
    NATURE REVIEWS DRUG DISCOVERY28965.90
    NATURE REVIEWS IMMUNOLOGY35170.80
    Lancet Respiratory Medicine7961.60
    BMJ-British Medical Journal010.20
    BMJ-British Medical Journal010.20


以上SCI期刊相关数据和信息来源于网络,仅供参考。
投稿状态统计: 我要评分:

    同领域作者分享投稿经验:共11条 (包含回复)

我来分享

    关闭窗口

    联系我们 | 站点地图 | 友情链接 | 授权代理商 | 加入我们

    © 2010-2023 中国: LetPub上海分公司    网站备案号:沪ICP备10217908号-1    沪公网安备号:31010402006960

    增值电信业务经营许可证:沪B2-20211595

    礼翰商务信息咨询(上海)有限公司      办公地址:上海市徐汇区漕溪北路88号圣爱大厦2103室

    United States: Tel: 1-781-202-9968 Address: 400 5th Ave, Suite 530, Waltham, Massachusetts 02451